These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 38912979)

  • 41. Medical Multimorbidity, Mental Illness, and Substance Use Disorder among Middle-Aged and Older Justice-Involved Adults in the USA, 2015-2018.
    Han BH; Williams BA; Palamar JJ
    J Gen Intern Med; 2021 May; 36(5):1258-1263. PubMed ID: 33051837
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Substance abuse treatment in correctional versus non-correctional settings: Analysis of racial/ethnic and gender differences.
    Pro G; Camplain R; Sabo S; Baldwin J; Gilbert PA
    J Health Dispar Res Pract; 2019; 12(3):1-20. PubMed ID: 33110710
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Gender Differences in Associations Between Attention-Deficit/Hyperactivity Disorder and Substance Use Disorder.
    Ottosen C; Petersen L; Larsen JT; Dalsgaard S
    J Am Acad Child Adolesc Psychiatry; 2016 Mar; 55(3):227-34.e4. PubMed ID: 26903256
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impact of Cannabis Use, Substance Use Disorders, and Psychiatric Diagnoses on COVID-19 Outcomes: A Retrospective Cohort Study.
    Ramakrishnan D; Sureshanand S; Pittman B; Radhakrishnan R
    J Clin Psychiatry; 2022 Aug; 83(5):. PubMed ID: 36044600
    [No Abstract]   [Full Text] [Related]  

  • 45. Demographic trends associated with substance use disorder and risk for adverse obstetric outcomes with cannabis and opioid use disorders.
    Logue TC; Wen T; Friedman AM
    J Matern Fetal Neonatal Med; 2022 Dec; 35(26):2128658. PubMed ID: 36617462
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The 3-Year Course of Multiple Substance Use Disorders in the United States: A National Longitudinal Study.
    McCabe SE; West BT
    J Clin Psychiatry; 2017 May; 78(5):e537-e544. PubMed ID: 28406266
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Risk factors for COVID-19 among persons with substance use disorder (PWSUD) with hospital visits - United States, April 2020-December 2020.
    Board AR; Kim S; Park J; Schieber L; Miller GF; Pike J; Cremer LJ; Asher A
    Drug Alcohol Depend; 2022 Mar; 232():109297. PubMed ID: 35033956
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prevalence, patterns, and correlates of multiple substance use disorders among adult primary care patients.
    John WS; Zhu H; Mannelli P; Schwartz RP; Subramaniam GA; Wu LT
    Drug Alcohol Depend; 2018 Jun; 187():79-87. PubMed ID: 29635217
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Substance Use Relapse Among Veterans at Termination of Treatment for Substance Use Disorders.
    Betancourt CA; Kitsantas P; Goldberg DG; Hawks BA
    Mil Med; 2022 Oct; 187(11-12):e1422-e1431. PubMed ID: 34272857
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Black clients in expansion states who used opioids were more likely to access medication for opioid use disorder after ACA implementation.
    Johnson NL; Choi S; Herrera CN
    J Subst Abuse Treat; 2022 Feb; 133():108533. PubMed ID: 34218991
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Utilization of addiction treatment among U.S. adults with history of incarceration and substance use disorders.
    Tsai J; Gu X
    Addict Sci Clin Pract; 2019 Mar; 14(1):9. PubMed ID: 30836991
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sexual orientation and gender identity disparities in substance use disorders during young adulthood in a United States longitudinal cohort.
    Jun HJ; Webb-Morgan M; Felner JK; Wisdom JP; Haley SJ; Austin SB; Katuska LM; Corliss HL
    Drug Alcohol Depend; 2019 Dec; 205():107619. PubMed ID: 31678835
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Patients admitted to treatment for substance use disorder in Norway: a population-based case-control study of socio-demographic correlates and comparative analyses across substance use disorders.
    Amundsen EJ; Bretteville-Jensen AL; Rossow I
    BMC Public Health; 2022 Apr; 22(1):792. PubMed ID: 35443672
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Risk of somatic diseases in patients with eating disorders: the role of comorbid substance use disorders.
    Mellentin AI; Nielsen DG; Skøt L; Støving RK; Guala MM; Nielsen AS; Wesselhoeft R; Mejldal A
    Epidemiol Psychiatr Sci; 2022 Oct; 31():e73. PubMed ID: 36245431
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treatment Utilization Among Adolescent Substance Users: Findings from the 2002 to 2013 National Survey on Drug Use and Health.
    Haughwout SP; Harford TC; Castle IJ; Grant BF
    Alcohol Clin Exp Res; 2016 Aug; 40(8):1717-27. PubMed ID: 27427179
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Substance Use Disorders (SUDs) and Risk of Cardiovascular Disease (CVD) and Cerebrovascular Disease (CeVD): Analysis of the Nationwide Inpatient Sample (NIS) Database.
    Patel H; Patel UK; Chowdhury M; Assaf AD; Avanthika C; Nor MA; Rage M; Madapu A; Konatham S; Vodapally M; Bhat V; Gnawali A; Mohamed M; Abdi N; Malik FA; Zughaib M
    Cureus; 2023 May; 15(5):e39331. PubMed ID: 37351248
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Examining Sex and Racial/Ethnic Differences in Co-use of Alcohol, Cannabis, and Cigarettes in a Community Sample of Adolescents.
    Purcell JB; Orihuela CA; Elliott MN; Tortolero Emery S; Schuster MA; Mrug S
    Subst Use Misuse; 2021; 56(1):101-110. PubMed ID: 33164639
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Substance use disorders and the risk of suicide mortality among men and women in the US Veterans Health Administration.
    Bohnert KM; Ilgen MA; Louzon S; McCarthy JF; Katz IR
    Addiction; 2017 Jul; 112(7):1193-1201. PubMed ID: 28301070
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid substance use disorders.
    Beaulieu S; Saury S; Sareen J; Tremblay J; Schütz CG; McIntyre RS; Schaffer A;
    Ann Clin Psychiatry; 2012 Feb; 24(1):38-55. PubMed ID: 22303521
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prevalence and correlates of alcohol and other substance use disorders in young adulthood: A population-based study.
    Latvala A; Tuulio-Henriksson A; Perälä J; Saarni SI; Aalto-Setälä T; Aro H; Korhonen T; Koskinen S; Lönnqvist J; Kaprio J; Suvisaari J
    BMC Psychiatry; 2009 Nov; 9():73. PubMed ID: 19925643
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.